FDA Clears SQI Diagnostics' Platform, Test for Celiac Disease

The test is SQI's second multiplexed assay cleared by the FDA to run on the SQIDworks platform.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories